insights_auto
Why is TCRX down 4,40%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
0,16 $
arrow_downward
-4,40%(-0,0074) 1D
13 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
0,17 $
High
0,17 $
Low
0,16 $
Mkt. cap
10,76 млн
Avg. vol.
547,00 м.
Volume
227,68 м.
52-wk high
1,47 $
52-wk low
0,16 $
EPS
-0,91 $
Beta
1,21
Shares outstanding
63,50 млн
No. of employees
43
Open
0,17 $
High
0,17 $
Low
0,16 $
Mkt. cap
10,76 млн
Avg. vol.
547,00 м.
Volume
227,68 м.
52-wk high
1,47 $
52-wk low
0,16 $
EPS
-0,91 $
Beta
1,21
Shares outstanding
63,50 млн
No. of employees
43
News stories
From web sources and news partners
TradingView
·
3 күн бұрын
TScan Therapeutics Q3 revenue drops after Amgen collaboration ends
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Массачусетс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitetscan.com